Investigator-Initiated Clinical Trials to assess the safety of SK-818 in patients with operable breast cancer
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 14 Nov 2017
At a glance
- Drugs Propagermanium (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 09 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 26 May 2017 Status changed from not yet recruiting to recruiting.
- 09 Jun 2016 New trial record